LabCorp completes acquisition of Chiltern for $1.2bn

US-based global life sciences company LabCorp has completed the acquisition of Chiltern, a specialist contract research organisation (CRO), for approximately $1.2bn.
Source: Pharmaceutical Technology - Category: Pharmaceuticals Source Type: news